Clearwater Strengthens Cyber Defense in Healthcare and the Defense Industrial Base with Enhanced Threat Intelligence from Google Cloud

Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment

START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials

START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem.

Amprion Announces Strategic Growth Initiatives, Expanding Access to Breakthrough SAAmplify Test

Appointment; Abzena Appoints Geoffrey M. Glass as Chief Executive Officer

Zymo Research and the Institute for Genome Sciences at the University of Maryland School of Medicine Partner to Host a BioFestival Supporting Scientific Innovation and Academic Research

I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing our partnership with the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine to co-host the BioFestival on October 17, 2025. This event is designed to support emerging scientists, promote interdisciplinary collaboration, and foster disruptive innovation in the life sciences. The BioFestival will feature interactive science booths, professional networking, and the BioDisruptor Grant Competition, where students will compete for over $9,000 in cash prizes and $20,000 in Zymo Research product credits and services. We believe this event will be of significant interest to your readers, especially those focused on life sciences, academic research, biotechnology innovation, and student-driven discovery. You can view the full press release here: https://www.zymoresearch.com/blogs/press-releases/university-of-maryland-biofestival

Linus Health Showcases Digital Breakthroughs to Advance Early Detection and Personalization in Brain Health at AAIC 2025

Linus Health Showcases Digital Breakthroughs to Advance Early Detection and Personalization in Brain Health at AAIC 2025

Zymo Research Sets New Standard in NGS Library Prep with Endura™ Tn5 Transposase

I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing the launch of Endura™ Tn5 Transposase, a next-generation solution for NGS library preparation workflows. Endura™ Tn5 is specifically engineered for enhanced stability and consistent performance in NGS-based applications. This innovation addresses long-standing challenges in Tn5 technologies, including enzyme instability and variability in fragmentation results. We believe this launch will be of significant interest to your readers in genomics, molecular biology, sequencing technologies, and life science research. You can view the full press release here: https://www.zymoresearch.com/blogs/press-releases/zymo-research-endura-tn5-transposase We would greatly appreciate it if you would consider sharing this news with your readers. If you require any additional information, high-resolution images, or would like to arrange an interview with one of our experts, please do not hesitate to reach out. I look forward to the opportunity to collaborate with your team. Thank you for your time and consideration.

PhenoTips Appoints Growth Driver Parker Lachance as Vice President of Revenue

PhenoTips, a leading provider of precision medicine software, announces today the appointment of Parker Lachance as VP of Revenue. Parker Lachance brings to PhenoTips an extensive history scaling start-ups through sales, marketing, and customer success strategy, most recently as Vice President of Revenue Operations at Smile Digital Health.

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-Class Scientific Research

Dear GenomeWeb Editorial Team, I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing the upcoming BioFestival at Harvard University, taking place on October 18, 2025. We believe this event will resonate strongly with your audience, especially those engaged in life sciences, academic research, and biotech innovation. The press release highlights Zymo Research’s partnership with Harvard to celebrate disruptive research, foster academic-industry collaboration, and promote sustainable scientific innovation. With over $9,000 in cash awards and $20,000 in research funding at stake, this event empowers students to advance their research and connect with leaders in the life science community. We invite you to read the full press release here: https://www.zymoresearch.com/blogs/press-releases/harvard-university-biofestival

Sharp's Emissions Reduction Targets Validated by Science Based Targets initiative

Integrated DNA Technologies Announces Translational CRISPR Portfolio Expansion with Product Innovation Updates

New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapies

Proscia Cements Leadership in Diagnostic Pathology with 400% Growth in Daily Cases

This momentum reflects the company’s strong role as a trusted partner to major laboratories worldwide as it helps them to unlock the clinical, operational, and financial value of AI-driven pathology at scale.

Huateng Pharma Highlights the Expanding Role of N-Benzylhydroxylamine Hydrochloride in Drug Discovery

Huateng Pharma spotlights N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7), a versatile compound used in drug synthesis and biomedical research. Known for its role in HDAC inhibitor development, the compound also shows potential in metal chelation, antioxidant activity, and enzyme modulation. Huateng Pharma supports ongoing pharmaceutical innovation by providing high-purity intermediates like this for global research and development.

Quotient Sciences Announces Formation of Scientific Advisory Board

BIOPHARMA PEG Achieves FDA DMF Listings for Two PEG-Based Drug Conjugation Reagents

BIOPHARMA PEG has received FDA Drug Master File (DMF) numbers for two PEG-based intermediates: mPEG-pALD 20K (DMF 040600) and HZ-PEG-HZ (1K) (DMF 041864). These compounds are commonly used in drug conjugation, controlled release, and nanoparticle modification applications, and their DMF listings provide regulatory support for pharmaceutical development.

Massachusetts Health Data Consortium and ZeOmega Launch Statewide Initiative to Automate Prior Authorization

Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion

Qureight’s deep-learning image biomarkers and clinical data analytics platform used to analyse enrolled idiopathic pulmonary fibrosis (IPF) patient data, supporting efficacy outcome and expansion to larger global patient studies

Vector Laboratories Launches Glysite™ Explorer in situ PLA Glycan Detection Kit to Advance Functional Proteomics Research

Vector Laboratories and Navinci launched the Glysite™ Explorer in situ PLA Glycan Detection Kit, the first commercially available tool to spatially detect protein glycosylation in FFPE tissues and fixed cells. By combining Vector’s validated lectins with Navinci’s in situ PLA technology, the kit offers researchers a streamlined, reproducible way to study glycan-protein proximity and gain deeper insight into disease biology and biomarker discovery.

Hongene Supports Clinical Advancement of siRNA DNV001 Using Proprietary Chemoenzymatic Ligation Platform